Front page / What’s new

What's New

Here you will find information about cancer care and research, news, articles, patient stories and other materials about our work and services. Our Communications serves media and journalists and please contact our Communications via, viestinta@docrates.com.

News | 05.12.2022

We are renewing the pricing of our services starting

Nov 24, 2022 | We are renewing the pricing of our services starting from January 1st 2023, due to the...

Press releases | 24.11.2022

Docrates Cancer Center celebrates its 15th anniversary – one step ahead of cancer

Nov 24, 2022 | The private cancer hospital Docrates Cancer Center is celebrating its 15th anniversary this year. Docrates Cancer...

Articles | 19.10.2022

Prostate cancer

Study: How cancer affects your sex life – “It’s good to remember that sexuality is not the same as intercourse,” says Professor Timo Joensuu

Oct 19, 2022 | Cancer can be difficult both physically and mentally. It can have a major impact on your...

Articles | Press releases | 31.08.2022

Breast cancer Treatments

Breakthroughs in the treatment of metastatic breast cancer

Aug 31, 2022 | New forms of drug therapy can almost double the life expectancy of patients with advanced breast...

News | Press releases | 09.06.2022

Career story

Docrates Cancer Center has appointed Anna-Sofia Malmi as Marketing and Communications Director

Jun 9, 2022 | Anna-Sofia Malmi, M.Sc (Education), has been appointed as Marketing and Communications Director at Docrates Cancer Center...

Articles | 10.05.2022

Prostate cancer

Accurate information on aggressiveness and tumor staging form the basis for prostate cancer treatment

In western countries, prostate cancer is the most common cancer type in men. In its early stages, it is often...

Articles | 03.05.2022

A visionary for all cancer patients – steps in the history of Docrates

When Timo Joensuu set out in the mid-2000s to establish the first private cancer hospital in the Nordic countries, the...

Articles | 12.04.2022

Should low-risk prostate cancer be left to active monitoring?

Active treatment vs. monitoring of localised low-risk prostate cancer has long been a contested topic. According to the results of...

Articles | 08.04.2022

Breast cancer

Docrates uses the newest drug therapies for breast cancer

New cancer drugs are being developed all the time, and new uses are being found for drugs already in use.

Press releases | 01.02.2022

Gene profilering

“The future of cancer treatment” is already a reality in Finland – gene profiling may benefit all cancer patients

- Gene profiling is a new method for examining the characteristics of cancer tumors, which is currently useful in the...

Articles | 07.01.2022

Treatments

One type of cancer is distinct from others due to its painfulness—these everyday methods can alleviate the pain, and sauna is not necessarily one of them

7.1.2022 | As cancer becomes metastasised, it typically causes more pain. Oncologist Olga Maslennikova from Docrates Cancer Center shares the...